Tech and Drugs - Podcast
Today: #132 in Science, Japan on our combined chart.
Chart positions today · Brazil
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Tech and Drugs - Podcast, try…
Ranking history · Brazil
Latest episodes
-
Can AI Make Biomedical Research 10× Faster? | Stephan Reichl
October 5, 2026 · 1 hr 11 minCan AI compress years of biomedical research into months? And if it can speed up literature reviews, coding and data analysis, what happens when the next step still depends on an experiment?I’m joined by Stephan Reichl, a biomedical data…
-
From LIMS to Autonomous AI Scientists — Kevin Cramer (Sigmatic Sciences) | Tech & Drugs
September 22, 2026 · 1 hr 3 minKevin Cramer has spent over two decades in lab informatics. He founded Sapio Sciences, unifying LIMS and electronic lab notebooks into a single R&D platform, and now leads Sigmatic Sciences, building autonomous, agentic AI systems and…
-
Making “Undruggable” Proteins Druggable? | Dr. Linker & Dr. Schnee, Merck KGaA, Darmstadt, Germany
September 9, 2026 · 1 hr 5 minIn this episode of Tech & Drugs, I sit down with Dr. Stephanie Linker and Dr. Philipp Schnee from Merck KGaA, Darmstadt, Germany to explore how AI is changing protein design, drug discovery, and the role of scientists.We discuss de novo…
-
When AI Generates the Scientific Hypothesis | Mathieu Bourdenx, UK Dementia Research Institute @UCL
July 21, 2026 · 58 minIn this Tech & Drugs episode, I sit down with Mathieu Bourdenx, Group Leader at the UK Dementia Research Institute / UCL, to explore how AI agents and AI co-scientists are beginning to change neuroscience research.We discuss brain aging…
-
Can AI Reduce Animal Testing in Toxicology? With Dr. Thomas Steger-Hartmann
July 8, 2026 · 1 hr 13 minIn this Tech & Drugs episode, I sit down with Thomas Steger-Hartmann, former investigational toxicology lead at Bayer and industry lead of the VICTOR Consortium, to explore the future of drug safety.We discuss how toxicology is moving from…
Show 7 more episodesShow fewer episodes
-
AI in Pharma: From Molecule to Market with Siemens' Patrick Ansems
June 30, 2026 · 36 minIn this Tech & Drugs episode, I sit down with Patrick Ansems, globally responsible for life sciences strategy at Siemens across pharma and medical devices, to explore how AI, data, automation, and platforms are reshaping drug…
-
AI, Autonomous Labs, and the Future of Science - Laura Matz (Merck KGaA, Darmstadt, Germany)
June 18, 2026 · 54 minIn this Tech & Drugs episode, I sit down with Laura Matz, Chief Science and Technology Officer at Merck KGaA Darmstadt, Germany, to explore how AI, data, automation, and digital technologies are reshaping science at scale.Laura brings a…
-
Servier's Walid Kamoun on AI and the Future of Oncology R&D
May 28, 2026 · 1 hr 0 minIn this Tech & Drugs episode, I sit down with Walid Kamoun, VP and Global Head of Oncology R&D at Servier, to explore how AI is changing oncology drug discovery and development.We discuss where AI is already useful today, what remains…
-
From Code to Cells: Dov Gertz of Converge Bio on Generative AI and the Future of Drug Discovery
April 21, 2026 · 39 min🎙 Tech and Drugs – Season 02, Episode 03From Code to Cells: Dov Gertz of Converge Bio on Generative AI and the Future of Drug DiscoveryIn this episode, I sat down with Dov Gertz, CEO and co-founder of Converge Bio, a company pushing…
-
From Tennis Courts to Molecular Design: Tim Hoctor on Data, Discovery, and the Future of Pharma
March 3, 2026 · 49 min🎙 Tech and Drugs – Season 02, Episode 02From Tennis Courts to Molecular Design: Tim Hoctor on Data, Discovery, and the Future of Pharma Last December in Berlin, I had the privilege of sitting down with my friend and longtime mentor Tim…
-
Inside Scientific Publishing, AI, and the Future of Medical Knowledge with Mitja-Alexander Linss
February 4, 2026 · 33 min🎙 Tech and Drugs – Season 02, Episode 01Inside Scientific Publishing, AI, and the Future of Medical KnowledgeIn the opening episode of Season 2, I sat down with Mitja-Alexander Linss, Head of Marketing at Karger Publishers, one of the…
-
Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery
December 17, 2025 · 30 min🎙 Tech and Drugs – Episode #11Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug DiscoveryThis week I sat down with Rick Schneider, co-founder and CEO of Helical, a Luxembourg-based startup on a mission…